Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.
FASEB J. 2012 Feb;26(2):523-32. doi: 10.1096/fj.11-190850. Epub 2011 Oct 11.
The balance between bone-forming osteoblasts and bone-resorbing osteoclasts is crucial to bone homeostasis, an equilibrium that is disturbed in many bone diseases. The transcription factor Tal1 is involved in the establishment of hematopoietic stem cells in the embryo and is a master regulator of hematopoietic gene expression in the adult. Here, we show that Tal1 is expressed in osteoclasts and that loss of Tal1 in osteoclast progenitors leads to altered expression of >1200 genes. We found that DC-STAMP, a key regulator of osteoclast cell fusion, is a direct target gene of Tal1 and show that Tal1 represses DC-STAMP expression by counteracting the activating function of the transcription factors PU.1 and MITF. The identification of Tal1 as a factor involved in cell fusion contributes to the understanding of osteoclast-associated diseases, including osteoporosis.
成骨细胞和破骨细胞之间的平衡对于骨骼稳态至关重要,而这种平衡在许多骨骼疾病中被打破。转录因子 Tal1 参与胚胎造血干细胞的建立,是成年造血基因表达的主要调节因子。在这里,我们发现 Tal1 在破骨细胞中表达,破骨细胞前体细胞中 Tal1 的缺失导致 >1200 个基因的表达发生改变。我们发现,DC-STAMP 是破骨细胞细胞融合的关键调节因子,是 Tal1 的直接靶基因,并表明 Tal1 通过拮抗转录因子 PU.1 和 MITF 的激活功能来抑制 DC-STAMP 的表达。将 Tal1 鉴定为参与细胞融合的因子有助于理解与破骨细胞相关的疾病,包括骨质疏松症。